艾沃利單抗 ，Omburtamab， AntibodySystem Laboratories

標(biāo)題：艾沃利單抗 ，Omburtamab，CAS:1895083-75-6， AntibodySystem Laboratories

貨號(hào)：DHJ04002

產(chǎn)品鏈接：http://www.atagenix.com/product_detail-75194.html

別名：8H9, Mab 8H9, CAS: 1895083-75-6

簡介：

Omburtamab 是一種 anti-CD276 (也被稱為 B7-H3) 的單克隆抗體，CD276 是一種在人類實(shí)體腫瘤中表達(dá)的 B7/CD28 免疫球蛋白家族成員。Omburtamab 可以與腫瘤組織相結(jié)合，用于各種癌癥的研究。

貨號(hào)：DHJ04002

產(chǎn)品品牌：Antibodysystem

通用名：Omburtamab

純度：>95% by SDS-PAGE.

濃度：1mg/ml

Formulationicon：0.01M PBS, pH 7.4.

別名：8H9, Mab 8H9

靶點(diǎn);物種：Human CD276/B7-H3

種類：Mus musculus

受體鑒定：IgG1-kappa

CAS: 1895083-75-6

存儲(chǔ)條件：

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

參考文獻(xiàn)：

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies. PMID: 36371226

Antibodies to watch in 2020. PMID: 31847708

Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine. PMID: 31481583

IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab-pharmacokinetic modeling to optimize therapeutic index. PMID: 33047248

Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. PMID: 31405921

Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes. PMID: 33514401

Biodistribution and Radiation Dosimetry of Intraperitoneally Administered 124I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors. PMID: 34857661

B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study. PMID: 33119478

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma. PMID: 36853490

Radioimmunoscintigraphy and pre-treatment dosimetry of 131I-omburtamab for planning treatment of leptomeningeal disease. PMID: 36759197

Antibodies to watch in 2019. PMID: 30516432

Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes. PMID: 30879172

Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy. PMID: 33533945

Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma. PMID: 32977309

Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody. PMID: 34601396

Evaluation of a patient-specific algorithm for predicting distribution for convection-enhanced drug delivery into the brainstem of patients with diffuse intrinsic pontine glioma. PMID: 33990084